Proteomics & Protein Research
News on protein analysis, clinical proteomics, biomarkers in genetics, genomics, and molecular diagnostics.
Akoya Biosciences, Acrivon Therapeutics Partner to Develop CDx
The companies will codevelop, validate, and commercialize a companion diagnostic for Acrivon's targeted DNA damage response inhibitor therapy, ACR-368.
QIMR Berghofer Licenses Esophageal Cancer Blood Biomarkers to Proteomics International
Under the agreement, Proteomics International has the right to use the markers to develop and commercialize a blood-based early detection test for esophageal cancer.
OncoHost Licenses SomaLogic Platform to Develop Tests to Predict Patient Response to Immunotherapies
OncoHost will use the SomaScan platform to develop proteomic tests to also develop strategies to overcome treatment resistance.
InterVenn BioSciences Hits Commercial Phase, Launches Test for Immunotherapy Response in Melanoma
Premium
At the ASCO meeting this week, the firm will present validation data on the test, which predicts response to immune checkpoint inhibitors in advanced melanoma.
The firm is the latest iteration of the GMU spinout Theranostics Health, which has been working to drive clinical uptake of its technology for over a decade.